Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Fintel reports that on August 4, 2025, Stifel downgraded their outlook for Baxter International (NYSE:BAX) from Buy to Hold. Analyst Price Forecast Suggests 72.35% Upside As of July 17, 2025, the ...

While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential ...

Baxter saw its stock price plunge by more than 20% after it lowered its revenue projections for the remainder of this year, ...

Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is ...

Experts have speculated that claims like the plaintiff's could increase against defendants who maintain these ethylene oxide storage facilities or warehouses.

Baxter International Inc. ( NYSE: BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather ...